The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
about
Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testesFusion of the NUP98 gene with the LEDGF/p52 gene defines a recurrent acute myeloid leukemia translocationMicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemiaA novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility.Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocationThe structural basis for cancer treatment decisions.Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib.The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemiaEstablishment of a standardized multiplex assay with the analytical performance required for quantitative measurement of BCR-ABL1 on the international reporting scale.Nuclear microenvironment in cancer diagnosis and treatmentQuality control methods for optimal BCR-ABL1 clinical testing in human whole blood samplesMolecular techniques for the personalised management of patients with chronic myeloid leukaemia.Metabolic assessment of a novel chronic myelogenous leukemic cell line and an imatinib resistant subline by H NMR spectroscopy.A rare case of Philadelphia chromosome-positive chronic myelogenous leukemia with inversion in chromosome 9 and t(10;17).Characterization of the different BCR-ABL transcripts with a single multiplex RT-PCR.Organopalladium compound 7b targets mitochondrial thiols and induces caspase-dependent apoptosis in human myeloid leukemia cells.Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review.Mechanisms of receptor tyrosine kinase activation in cancer.
P2860
Q24310421-056A045F-3D16-4CB7-A1F2-C1C7C0CDD8A0Q24795713-781C886E-57F4-4B1E-8264-DDE99A2895BDQ26766288-275A6814-B9EC-45DC-9606-CA093AD1BB34Q30008897-1A6B2B53-B755-4D4B-AAB1-B87761142D27Q33262922-59ADC0EC-7D67-4755-B451-DB79B14CF392Q33513975-EEF215C2-FC0C-4688-96A0-9B439C826DB6Q34076060-1A6A03FB-FF5A-4AC1-9DAF-D7AB2E256E66Q34365654-C9F67D9D-2663-4664-8466-9CB59746C6EFQ35073935-17747987-D005-4479-98C0-9FDF432DA1D6Q35547514-EC902538-BC15-41E4-B4FA-23DE73956056Q35664358-01D7808C-1FF1-4314-9B9D-3E78BD761B59Q36810080-2E2BFE2B-C282-4959-82E7-0751696381BDQ36817650-DEBEE510-8A19-4E5B-84E7-240F99506988Q37696776-B3E4C584-FDF1-4A0F-9493-D80FA83EED9AQ39672888-99465305-3366-4A23-8908-65703020E293Q42089789-E1597800-0DD6-453D-B128-C7928E49B121Q42793838-A36181CB-749F-4019-869B-46963474240EQ43105269-4E18E3F9-77AE-440B-ACF2-7CA0D3D5B2ADQ47547350-FE81C965-12DB-4DA9-A006-AFFACA7AE563Q49888000-06CA84EB-36BD-40B3-BC13-C70470F2EAA1
P2860
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
@en
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
@nl
type
label
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
@en
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
@nl
prefLabel
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
@en
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
@nl
P2093
P1433
P1476
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
@en
P2093
P304
P407
P577
1993-01-01T00:00:00Z